Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Exercise/Conversion of 50,000 ZVRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 50,000 | n/a |
| Feb 10, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 37,500 | n/a |
| Feb 2, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 233,334 | n/a |
| Oct 10, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 50,000 | n/a |
| Feb 14, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale | 61,273 | $481.4K |
| Feb 10, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 225,000 | n/a |
| Feb 3, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Exercise/Conversion | 233,333 | n/a |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 7,693 | n/a |
| Feb 3, 2024 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 700,000 | n/a |
| Oct 11, 2023 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 600,000 | n/a |